StockStory.org on MSN

IART Q3 Deep Dive: Supply Chain Progress, Product Relaunches, and Margin Pressures Shape Outlook

Medical device company Integra LifeSciences (NASDAQ:IART) in Q3 CY2025, but sales rose 5.6% year on year to $402.1 million.

Seagate Q3: Build-To-Order Strategy Is Playing Out

Seagate Technology Holdings plc is rated a Strong Buy with a $305 price target and continued operational excellence. Learn ...